What is the safest way to check current Tesamorelin pricing?

Use official brand pages first, then confirm the exact cash-pay or insured amount with the prescribing service and dispensing pharmacy.

Does insurance always cover Tesamorelin?

No. Coverage depends on the specific plan, indication, and whether prior authorization is approved. Some plans may require step therapy or documentation of medical necessity.

Are there manufacturer savings programs for Tesamorelin?

Many branded peptide therapies offer savings cards or patient assistance programs. Eligibility typically requires commercial insurance and may exclude government programs like Medicare or Medicaid.

Structured page family:Cost guide

Tesamorelin Cost Guide: Insurance, Cash Pay, and Savings

In the United States, Tesamorelin costs depend on brand, pharmacy, insurance design, and whether the patient qualifies for manufacturer savings programs.

Active Market

This page is designed for US treatment decisions and uses US-first pricing and savings sources.

Official pricing

Verify current pricing directly on official Egrifta pages before starting, because list pricing, self-pay offers, and eligibility terms can change.

Cash-pay reality

Official cash-pay pricing varies by pharmacy and dose. Contact multiple pharmacies or use a prescription discount service for current rates.

Insurance coverage

Commercial coverage for Tesamorelin varies by plan and indication. Prior authorization is commonly required.

Savings and coupons

Manufacturer savings programs may reduce out-of-pocket cost for eligible commercially insured patients.

Prior Authorization

Prior authorization is common and may require documentation of diagnosis, prior treatments, and clinical need.

Price Breakdown

List price (monthly)

~$4,000-$5,000/month

Average wholesale price

~$3,800-$4,800/month

Pharmacy acquisition estimate

~$3,500-$4,500/month

Typical negotiated rate

~$2,800-$3,800/month

Price per dose

~$133 per 2 mg vial

Annual cost at list price

~$48,000-$60,000

Pharmacy Price Comparison

Pharmacy	Price Range	Notes
Specialty pharmacy	$3,800-$5,000/month	Required for distribution
Patient assistance	$0/month	For eligible uninsured patients

Insurance Coverage Landscape

Commercial plans

~60-70% with HIV lipodystrophy documentation

Medicare Part D

Coverage variable; may require formulary exception

Medicaid

Some states cover with prior auth

VA coverage

Available through VA for eligible veterans

TRICARE

Case-by-case coverage

Employer plan typical tier

Tier 4-5 specialty; coinsurance 25-40%

Prior Authorization Guide

Required Documentation

•HIV diagnosis
•Documented lipodystrophy (excess trunk fat)
•Stable antiretroviral therapy
•Conservative measures failed

Common Denial Reasons

•Non-HIV lipodystrophy
•Insufficient documentation
•Plan excludes cosmetic indications

Appeal Template Points

•FDA-approved indication
•HIV-associated lipodystrophy documented
•Comorbidity impact (metabolic syndrome)

Expected timeline: 1-2 weeks

Savings Programs and Patient Assistance

Egrifta Patient Assistance

manufacturer

Eligibility: Uninsured/underinsured, ≤500% FPL

Savings: Free or reduced

Income limit: ≤500% FPL

Enrollment: complex

Theratechnologies program

Copay assistance

copay

Eligibility: Commercially insured

Savings: May reduce to $0-$100

Income limit: None

Enrollment: moderate

Annual cap may apply

Generic and Biosimilar Status

No generic currently available

Expected: No generic expected

Cost by Dose

Dose/Regimen	Monthly	Annual
2 mg daily	$4,000-$5,000	$48,000-$60,000

Annual Cost Projection

Year 1

$0-$60,000

Year 2

$0-$60,000

Year 3

$0-$60,000

Assumptions

•No generic
•PAP eligibility

Cost-Saving Strategies

1.Apply for patient assistance immediately if uninsured
2.Ensure thorough documentation of HIV lipodystrophy for prior auth
3.Work with specialty pharmacy for insurance navigation

International Price Comparison

Country	Price Range	Notes
Canada	Limited availability	Specialty import

Need help comparing tesamorelin paths?

Use the provider matcher to package treatment interest, insurance, budget, urgency, and state context before you commit to a prescribing path.

Find a tesamorelin provider

Next Step

Use the cost calculator

Use provider matching when you need help comparing insured and self-pay treatment paths.

Open tool →

Retention Path

Join the Tesamorelin tracker waitlist

Capture refill timing, weekly dose history, and symptom notes in one planned workflow.

View tracker landing →

Trust Summary

Reviewed 2026-04-27 by PeptideScholar editorial review. This page currently cites 3 official sources.

Pricing, savings eligibility, and coverage rules can change quickly. Verify all current figures and terms directly on official brand pages before acting.

Tesamorelin Cost FAQ

Sources

1. Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy.
Drugs • 2011
Claim type: review
View source →
2. Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial.
Lancet HIV • 2019
Claim type: clinical
View source →
3. Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial.
Arch Neurol • 2012
Claim type: clinical
View source →

This content is for informational purposes only and does not constitute medical advice.